Complementary medicines during cold and flu season

As cold and flu season reaches fever pitch, the demand for complementary medicines to help prevent and manage colds and influenza is increasing. A...

Efficacy of antiplatelets in deep venous thrombosis

Venous thromboembolism (VTE) is the third most common cardiovascular disease in the world. Every year, 30,000 people in Australia develop VTE, at a cost of $1.72 billion to the Australian health system.

Pharmacy Board’s measured step on prescribing

The Pharmacy Board of Australia has recognised that pharmacists should be able to prescribe under two monitored models of prescribing, in a move welcomed...

Lead-up to medicine error

Mr Sotirios Temopoulos had a medical history that included multiple myeloma with a myelomataus lesion in his cervical spine, in which he was prescribed...

Quick Q&A with Katherine Higgins MPS

Jennifer Cooke, the Editor of Australian Pharmacist, talks with Katherine Higgins, a pharmacist in South Perth, Western Australia.

Nasal swab offers hope for reducing vancomycin use

A study has found a pharmacy-driven protocol using nasal swabs to assess methicillin‑resistant Staphylococcus aureus (MRSA) in pneumonia cases holds promise for reducing unnecessary...